At first glance to name of this drug appears to be that of either a very fast car or some sort of nasty water infection. It is In fact the name that has been given to a new anti Leukaemia drug which could offer hope to many people suffering from CML.
Professor John Goldman, Europe's leading authority on leukaemia, said: 'Usually these things are blown out of proportion, but this is real.' Dr David Secher, of the Cancer Research Campaign, said the drug is a product of a new phase of research into cancer treatment. 'In the next ten or 15 years, we are going to see better treatments for all types of cancer, including the common tumours,' he added.
British experts are taking part in the next, much larger, phase of tests on STI-571 ? due to begin early next year in the United States, the UK, France, Germany and Switzerland. The patients in the pilot study had chronic myeloid leukaemia (CML), a form of the disease which progresses slowly before switching to a rapid and fatal acute phase.
To Read more Click HERE to visit the Mail Online Webpage.